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TO THE EDITOR
During the past 35 years, assisted reproductive technology has been transformed from a 
miracle to a standard and common part of medical practice. Although this technology is 
believed to be safe and has resulted in more than 5 million infants born globally, rapid 
technological progress leading to treatment modifications makes it important to continually 
monitor the safety of assisted reproductive technology for the rapidly growing population of 
users of the technology and infants conceived with its use.
Although many countries have national registries to monitor the use and effectiveness of 
assisted reproductive technology, they are typically not designed to collect data beyond 
delivery. In the United States, the Centers for Disease Control and Prevention (CDC) 
maintains the National ART (Assisted Reproductive Technology) Surveillance System 
(NASS), which collects limited information about treatment outcome (live birth data are 
limited to plurality, infant sex, birth weight, and gestational age). Studying the long-term 
health outcomes of assisted reproductive technology is difficult owing to the relative 
infrequency of both the exposure to it and the outcomes of interest (e.g., birth defects, 
cancer, and developmental disorders) and to the sensitive nature of the fertility treatments. 
Our knowledge of the long-term effect of assisted reproductive technology on maternal and 
child health is thus quite limited.1
To better understand the effect of assisted reproductive technology on maternal and child 
health and to improve state-based surveillance, in 2001 the CDC’s Division of Reproductive 
Health initiated linkage of the NASS data with Massachusetts birth-certificate data. This 
small pilot project has since grown into the States Monitoring ART (SMART) 
Collaborative, which includes Massachusetts, Michigan, Florida, and Connecticut, with 
creative integration of existing surveillance systems and registries (e.g., hospital-discharge, 
birth-defects, and cancer registries) and broad collaboration among the federal government, 
state health departments, universities, and professional societies.2 The SMART 
Collaborative serves as a platform for researchers to study the short- and long-term 
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outcomes of assisted reproductive technology, drawing from the large sample of infants 
conceived with the use of this technology. The collaborative is also used for state-based 
monitoring of one of the most serious and costly adverse consequences of assisted 
reproductive technology — preterm births, which are estimated to result in a societal 
economic burden of more than $1.3 billion annually (Table 1).3,4
The field of assisted reproductive technology would benefit from closer monitoring of its 
safety. The renewed emphasis on patient safety in the United States5 calls for developing 
new tools or adapting old ones to identify the problem, to address the problem, and to 
measure progress. The integration of existing surveillance systems and registries could 
create an efficient infrastructure for conducting both important population-based, patient-
centered research on the outcomes of assisted reproductive technology and state-based 
public health surveillance aimed at protecting maternal and child health.
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Table 1
Infants, Preterm Infants, and the Societal Economic Burden of Preterm Births Conceived through Assisted 
Reproductive Technology in the United States (2010).*
State, District, or Territory Infants Conceived through Assisted Reproductive Technology
Total No. of Infants No. of Preterm Infants Societal Economic Burden Associated with Preterm 
Infants
2013 $
California 7,540 2,573 158,800,414
New York 6,258 2,008 123,929,744
Texas 4,347 1,998 123,312,564
New Jersey 3,803 1,420 87,639,560
Illinois 3,775 1,325 81,776,350
Massachusetts 3,480 1,035 63,878,130
Florida 2,402 994 61,347,692
Pennsylvania 2,162 754 46,535,372
Virginia 1,931 683 42,153,394
Maryland 1,856 602 37,154,236
Ohio 1,512 542 33,451,156
Michigan 1,460 527 32,525,386
North Carolina 1,455 557 34,376,926
Connecticut 1,404 463 28,575,434
Georgia 1,390 552 34,068,336
Washington 1,318 442 27,279,356
Minnesota 1,050 353 21,786,454
Colorado 994 417 25,736,406
Arizona 921 374 23,082,532
Indiana 705 308 19,009,144
Missouri 672 289 17,836,502
Wisconsin 568 215 13,269,370
Oregon 560 212 13,084,216
Iowa 541 199 12,281,882
Utah 522 237 14,627,166
South Carolina 521 226 13,948,268
Nevada 479 236 14,565,448
Tennessee 458 167 10,306,906
Kentucky 453 187 11,541,266
Louisiana 415 176 10,862,368
Oklahoma 369 170 10,492,060
Alabama 368 148 9,134,264
District of Columbia 337 103 6,356,954













Kissin et al. Page 4
State, District, or Territory Infants Conceived through Assisted Reproductive Technology
Total No. of Infants No. of Preterm Infants Societal Economic Burden Associated with Preterm 
Infants
2013 $
Kansas 315 116 7,159,288
New Hampshire 288 68 4,196,824
Idaho 244 112 6,912,416
Rhode Island 239 80 4,937,440
Hawaii 236 111 6,850,698
New Mexico 229 89 5,492,902
Nebraska 210 94 5,801,492
Delaware 204 56 3,456,208
Arkansas 203 69 4,258,542
Mississippi 163 66 4,073,388
West Virginia 124 42 2,592,156
Montana 105 42 2,592,156
Other states and territories 533 201 12,405,318
Total 59,119 21,638 1,335,454,084
*
The state, district, or territory indicates the place of patient residency; in cases of missing residency data (4%), we used the place in which the 
assisted-reproductive-technology procedure was performed; states or territories with fewer than 100 infants conceived through assisted 
reproductive technology were included in the category for other states and territories. Data on all infants and preterm infants conceived through 
assisted reproductive technology are from Sunderam et al.3 Calculations of societal economic burden were based on an assumption of an average 
burden of $51,600 ($61,718 in 2013 U.S. dollars) per infant born preterm, in accordance with calculations from the Institute of Medicine.4
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